ASCO 2019 – Lenalidomide reduces risk that smoldering myeloma will progress to myeloma in high risk patientsConferences, Myeloma31 May 2019
Lenalidomide and pomalidomide based triplet combination regimens for myeloma patients receives approval from the European CommissionAccess, Myeloma23 May 2019
Results of MPE members participation in EMA survey on bortezomibMPE, Myeloma, Patient evidence3 May 2019
MPE will hold a webinar on ASH 2018 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, Myeloma16 January 2019
Daratumumab increases progression-free survival in newly diagnosed myeloma patients ineligible for transplantMyeloma5 December 2018
New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, Myeloma4 December 2018
Horizon2020 CARAMBA video on CAR-T cell therapy now available in five languagesMPE, Myeloma, Videos1 October 2018
